Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) Enterprise Value: 2009-2025

Historic Enterprise Value for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to $240.5 million.

  • Lifecore Biomedical's Enterprise Value rose 47.38% to $240.5 million in Q2 2025 from the same period last year, while for May 2025 it was $217.2 million, marking a year-over-year increase of 60.62%. This contributed to the annual value of $240.5 million for FY2025, which is 47.38% up from last year.
  • Lifecore Biomedical's Enterprise Value amounted to $240.5 million in Q2 2025, which was up 18.91% from $202.3 million recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical's Enterprise Value registered a high of $350.4 million during Q2 2021, and its lowest value of $163.2 million during Q2 2024.
  • Moreover, its 3-year median value for Enterprise Value was $219.0 million (2023), whereas its average is $212.6 million.
  • Its Enterprise Value has fluctuated over the past 5 years, first plummeted by 49.82% in 2023, then surged by 47.38% in 2025.
  • Over the past 5 years, Lifecore Biomedical's Enterprise Value (Quarterly) stood at $254.8 million in 2021, then dropped by 5.12% to $241.8 million in 2022, then fell by 5.81% to $227.7 million in 2023, then decreased by 4.97% to $216.4 million in 2024, then spiked by 47.38% to $240.5 million in 2025.
  • Its Enterprise Value was $240.5 million in Q2 2025, compared to $202.3 million in Q1 2025 and $216.4 million in Q4 2024.